Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth ...
Baron Funds, an investment management company, released its “Baron Fifth Avenue Growth Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund experienced an ...
Today, Benzinga's options scanner identified 8 options transactions for Illumina. This is an unusual occurrence. The ...
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth year in a row to the Dow Jones Best-in-Class World Index and the Dow ...
Illumina shares ticked down 0.2% after China placed restrictions on the company as it caught itself in the country's crosshairs in response to a developing trade war. Shares were trading around $84.10 ...
Next-generation sequencing (NGS) technology, which has been used at Illumina since 2007, builds upon earlier genome sequencing methods to greatly reduce the time taken to sequence DNA. When ...
Illumina is a prominent entity in the genomic sequencing market, providing advanced DNA sequencing platforms and associated products. Its technologies are vital across research, clinical ...
Illumina forecasts 2025 revenue largely below estimates Gene sequencing machine maker Illumina ... will be added to the tech-heavy Nasdaq-100 Index, the exchange operator said on Friday, ...
The stock is down 36% over the last year. China's Ministry of Commerce on Tuesday also said it will prohibit Illumina from exporting gene sequences to China after being placed on the "unreliable ...